Dr. Delasos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 216-444-6833Fax+1 216-444-9464
Education & Training
Lake Erie College of Osteopathic Medicine - Seton HillClass of 2017
Certifications & Licensure
OH State License 2021 - 2025
CT State License 2017 - 2021- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mut...Isao Miyazaki, Igor Odintsov, Keiji Ishida, Allan J W Lui, Masanori Kato
Nature Cancer. 2023-10-01 - 6 citationsClinical Outcomes With Pembrolizumab-Based Therapies in Recurrent/Refractory NSCLC After Chemoradiation and Consolidative Durvalumab.Lukas Delasos, Wei Wei, Khaled A Hassan, Nathan A Pennell, Pradnya Patil
Clinical Lung Cancer. 2023-09-01 - 6 citationsVepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.Isao Miyazaki, Igor Odintsov, Keiji Ishida, Allan J W Lui, Masanori Kato
Nature Cancer. 2023-09-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
